Singular Genomics Appoints John Stark as CEO

Apr 30, 2026
Singular Genomics Systems has appointed John Stark as Chief Executive Officer as the company expands its spatial genomics platform and focuses on broader adoption in translational research and clinical applications.
Singular Genomics Appoints John Stark as CEO

Singular Genomics has appointed John Stark as Chief Executive Officer, announced in a press release. The leadership change comes as the company advances its spatial genomics platform and seeks to expand adoption across research and clinical markets.

Stark succeeds Josh Stahl, who will transition to the role of Independent Director on the Board. The company stated that with its G4X Spatial Sequencer now commercially available, the focus will shift to scaling operations and strengthening strategic partnerships.

John Stark brings more than 25 years of experience in commercializing life science technologies. He previously served as CEO of Resolve Biosciences, Quantum-Si, and Celsee, and held senior roles at Life Technologies, Pacific Biosciences, and Affymetrix.

Based in San Diego, Singular Genomics develops high throughput spatial pathology solutions for translational research, drug development, and precision medicine.

We hope you enjoyed this article

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.